
|Articles|July 16, 2019
Optimal Just-in-Time & Cancer Treatment Centers of America Collab to Change Trial Paradigm
Advertisement
Optimal Just-in-Time and Cancer Treatment Centers of America (CTCA) are collaborating to speed patient enrollment in oncology clinical trials. The collaboration is particularly significant at a time when seeking patients for oncology trials represents a unique challenge for pharmaceutical and biotech companies.
To learn more, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
2
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
3
Rethinking Operational Models to Reduce Site Burden in 2026
4
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
5




